Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phl p 1 is the major allergen from timothy grass (*Phleum pratense*), recognized by more than 90% of individuals allergic to grass pollen. It is a glycoprotein localized in the cytoplasm and outer layer of mature pollen grains, released upon hydration during pollination. Phl p 1 triggers strong IgE responses in allergic individuals, leading to respiratory symptoms such as allergic rhinitis and asthma exacerbations. It induces the release of pro-inflammatory mediators from respiratory epithelial cells. Measurement of specific IgE against Phl p 1 helps confirm sensitization due to genuine exposure to timothy or related grasses.
Not applicable - Phl p 1 is an allergen, not a drug target. However, drugs targeting downstream effects (e.g., antihistamines, corticosteroids) are used to manage the allergic response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Timothy Grass Major Allergen (Phl p 1).